Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Debt

Note 9 - Debt
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Debt Disclosure [Text Block]
Notes Payable
the Company issued
notes payable totaling
as a portion of the consideration paid in connection with the Company’s various acquisitions. Interest rates for both notes were
with maturities through
May 2017.
There was
outstanding note with a balance of
which was paid in
February 2019.
Credit and Security Agreement
January 3, 2017,
the Company entered into a Credit and Security Agreement (the “Credit Agreement”) and signed a revolving credit note payable to the lender. Under the Credit Agreement, the Company is able to borrow up to an aggregate of
under revolving loans. Interest on the unpaid outstanding principal amount of any revolving loans is at a rate equal to
per annum, provided that the minimum amount of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is
Interest is due and payable on the last day of each fiscal quarter in an amount determined by the Company, but
less than
The Credit Agreement terminates in
December 2019,
unless sooner terminated in accordance with the provisions of the Credit Agreement. The Credit Agreement is collateralized by the assets in the Company’s company-owned or managed clinics. The Company is using the credit facility for general working capital needs. As of
March 31, 2019,
the Company had drawn
of the
available under the Credit Agreement.